Trials that have a more heterogeneous study population are more generalisable to clinical practice and potentially have more external validity. However, because of a number of societal and historical factors, it is a challenge for trials to achieve this desired heterogeneous population.
Find out how leading experts from the clinical trial space are combating these challenges by listening to this webinar!
Alongside the growing trend of value-based searches, I wanted to delve into why candidates prioritise companies that focus on fundamental principles and ethics which resonate with them, as opposed to other more material benefits. Find out why, here.
In this episode, Jack speaks with two Co-Founders at Centivax about life as successful entrepreneurs, the journey to acquisition, challenges and learnings - and using them to become an industry-defining author. Listen now.